USAEUROPEViVE
ABOUTSPONSORSHIPFOUNDATION
Logo Hlth
Logo Hlth
09 Apr 2024 | 03:00 PM GMT

How Digital Diagnostics Enable Precision Medicine

Anchored by:

Ricarda Gaentzsch
Director
IQVIA

Participants:

Ricarda Gaentzsch DirectorIQVIA
Ricarda Gaentzsch
DirectorIQVIA
Chandana Fitzgerald President, CommunityHLTH
Chandana Fitzgerald
President, CommunityHLTH
Carolina Rebecchi Health Product ManagerHealthanea
Carolina Rebecchi
Health Product ManagerHealthanea
Christina Niedermeyer Global Health Program LeadPlug and Play Tech Center
Christina Niedermeyer
Global Health Program LeadPlug and Play Tech Center
Hrvojka Kostelac Digital Health LeadTakeda Pharmaceutical
Hrvojka Kostelac
Digital Health LeadTakeda Pharmaceutical
Manuel Römer Chief Strategy & Business DevelopmentExploris Health AG
Manuel Römer
Chief Strategy & Business DevelopmentExploris Health AG
Myles Furnace Chief Commercial OfficerEolas Medical
Myles Furnace
Chief Commercial OfficerEolas Medical
Ralph Morales III Managing DirectorShokunin Ventures
Ralph Morales III
Managing DirectorShokunin Ventures
RG
Ricarda Gaentzsch Head of Genomic & Precision Medicine EMEAIQVIA
RG
Ricarda Gaentzsch
Head of Genomic & Precision Medicine EMEAIQVIA
Sheena Dempsey Chief Solutions Officer Indivi
Sheena Dempsey
Chief Solutions Officer Indivi
Soslan Dzgoev Senior ConsultantIQVIA
Soslan Dzgoev
Senior ConsultantIQVIA
Zina Manji Founder/Principal, Regulatory StrategistInnopathwayz, LLC
Zina Manji
Founder/Principal, Regulatory StrategistInnopathwayz, LLC

About this Meeting

In the age of rapid technological advancements, digital technologies are collecting patient data in various states of health and disease, in both clinical and home settings. The acceleration of advanced analytics, propelled by artificial intelligence and Big Data, is expanding possibilities to unlock the power of collected data. 

While the prospect of obtaining individualised insights and precision diagnosis holds significant potential to improve the predictive and prognostic power of traditional methods, regulatory uncertainty and ethical considerations hinder their adoption.

Join this meeting to discuss:  
  • How are digital diagnostics contributing to the personalisation of medical treatments?
  • How are digital diagnostics tested and validated to enable integration into clinical and research settings?
  • In what ways can collaboration between digital innovators, pharma and health systems overcome current challenges to harness the full potential of digital diagnostics?
We would like to remind you that our meetings are small and intimate sessions with a limited number of seats available, therefore we rely on your attendance and participation to ensure a high-quality and valuable meeting for all. If you are confirmed for this meeting we ask if you can please ensure your attendance on the day.